BEXIMCO PHARMA.GDR REGS 1 Net Asset Momentum
BEXIMCO PHARMA.GDR REGS 1 net asset momentum. BEXIMCO PHARMA.GDR REGS 1 (R2WA) recorded a net asset momentum of 9.0% as of June 2024, with net assets of €51.90 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore BEXIMCO PHARMA.GDR REGS 1 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of BEXIMCO PHARMA.GDR REGS 1 (2021–2024)
Net asset momentum of BEXIMCO PHARMA.GDR REGS 1 from 2021 to 2024. This chart tracks BEXIMCO PHARMA.GDR REGS 1's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is +9.0%, with net assets of €51.90 Billion EUR as of June 2024. See BEXIMCO PHARMA.GDR REGS 1 (R2WA) shareholders funds for net asset value and shareholders' equity analysis.
BEXIMCO PHARMA.GDR REGS 1 Net Asset Momentum by Year (2021–2024)
BEXIMCO PHARMA.GDR REGS 1 net asset momentum by year from 2021 to 2024. The table below shows the complete annual net asset history for BEXIMCO PHARMA.GDR REGS 1 from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see R2WA stock market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €51.90 Billion | €69.34 Billion | €17.44 Billion | ▲ +9.0% |
| 2023 | €47.62 Billion | €69.16 Billion | €21.54 Billion | ▲ +6.7% |
| 2022 | €44.64 Billion | €66.15 Billion | €21.51 Billion | ▲ +19.5% |
| 2021 | €37.36 Billion | €52.25 Billion | €14.88 Billion | — |